BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 3224366)

  • 1. Amino acids and their derivatives as radioprotective agents.
    Roberts JC
    Amino Acids; 1992 Feb; 3(1):25-52. PubMed ID: 24192988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioprotective effect of N-acetylcysteine on granulocyte/macrophage colony-forming cells of human bone marrow.
    Selig C; Nothdurft W; Fliedner TM
    J Cancer Res Clin Oncol; 1993; 119(6):346-9. PubMed ID: 8449972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chemical radiation protectors on cell cycle progression after gamma or neutron irradiation.
    Sigdestad CP; Bergquist BL; Grdina DJ
    Cell Prolif; 1991 May; 24(3):271-80. PubMed ID: 2039803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065).
    Grdina DJ; Constantinou A; Shigematsu N; Murley JS
    Radiat Res; 1994 Apr; 138(1):44-52. PubMed ID: 8146299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
    Khodarev NN; Kataoka Y; Murley JS; Weichselbaum RR; Grdina DJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):553-63. PubMed ID: 15380592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II.
    Snyder RD; Grdina DJ
    Cancer Res; 2000 Mar; 60(5):1186-8. PubMed ID: 10728671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells.
    Murley JS; Constantinou A; Kamath NS; Grdina DJ
    Cell Prolif; 1997; 30(6-7):283-94. PubMed ID: 9451419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle redistribution of cultured cells after treatment with chemical radiation protectors.
    Sigdestad CP; Guilford W; Perrin J; Grdina DJ
    Cell Tissue Kinet; 1988 May; 21(3):193-200. PubMed ID: 3224366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical mechanisms of action of radioprotective drugs].
    Romantsev EF
    Radiobiologiia; 1967; 7(5):689-97. PubMed ID: 4902540
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of radioprotectors on DNA damage and repair, proteins, and cell-cycle progression.
    Grdina DJ; Guilford WH; Sigdestad CP; Giometti CS
    Pharmacol Ther; 1988; 39(1-3):133-7. PubMed ID: 3059364
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical basis for the effects of radioprotective substances].
    Romantsev EF; Blokhina VD; Zhulanova ZI; Koshcheenko NN; Filippovich IV
    Radiobiologiia; 1977; 17(5):672-86. PubMed ID: 339265
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioprotection by antioxidants.
    Weiss JF; Landauer MR
    Ann N Y Acad Sci; 2000; 899():44-60. PubMed ID: 10863528
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.